Avitar Long Term Debt 1971-1970 | AVTI

Avitar long term debt from 1971 to 1970. Long term debt can be defined as the sum of all long term debt fields.
Avitar Annual Long Term Debt
(Millions of US $)
Avitar Quarterly Long Term Debt
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
Avitar, Inc. (Avitar), through its wholly owned subsidiary Avitar Technologies, Inc. (ATI), develops, manufactures, markets and sells diagnostic test products and hydrophilic polyurethane foam disposables fabricated for medical, diagnostics, dental and consumer use. The Company continued the development and marketing of point-of-care oral fluid drugs of abuse tests, which use the Company's foam as the means for collecting the oral fluid sample. Avitar sells its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies and corporations. The Company continues to have applications for its technologies in a variety of other medical/consumer markets. They include a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. Customers for these products include ArthroCare and National Aeronautics and Space Administration (NASA).
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.805B 21.44
Becton Dickinson (BDX) United States $51.260B 12.69
Cardinal Health (CAH) United States $38.083B 19.94
Straumann Holding AG (SAUHY) Switzerland $20.857B 0.00
West Pharmaceutical Services (WST) United States $15.151B 31.76
Cooper (COO) United States $14.525B 18.72
Align Technology (ALGN) United States $13.828B 27.45
Henry Schein (HSIC) United States $8.411B 14.43
Merit Medical Systems (MMSI) United States $4.906B 23.72
DENTSPLY SIRONA (XRAY) United States $3.125B 9.33
CONMED (CNMD) United States $1.474B 11.03
STAAR Surgical (STAA) United States $0.860B 0.00
Lifevantage (LFVN) United States $0.163B 16.84
Pro-Dex (PDEX) United States $0.151B 16.50